Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests
- PMID: 21084770
- DOI: 10.1507/endocrj.k10e-224
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests
Abstract
Since there is increasing evidence that postprandial hyperglycemia is a risk factor for the development of macrovascular complications, it is important to predict postprandial hyperglycemia in the early stages of glucose intolerance, and routine medical checkups provide a good opportunity to do so. The aim of this study was to evaluate the usability of 1,5-anhydroglucitol (1,5-AG) in routine medical checkups. The subjects were 77 Japanese men who participated in a routine medical checkup. First, we performed 75 g oral glucose tolerance tests (OGTTs), and examined the changes in glucose and 1,5-AG levels measured at 0, 30, 60, 90, 120, and 180 minutes (min). 1,5-AG levels did not significantly change until 90 min after the glucose load. Second, a linear regression analysis showed an inverse correlation between the 2-hour post-challenge glucose (2h-PG) and baseline 1,5-AG levels during the OGTT (P = 0.001, r(2) = 0.13), and the correlation was still significant after adjustment for age (2h-PG = 170 + 0.83 × (age in years) - 3.23 × (1,5-AG), P = 0.002, adjusted r(2) = 0.12). Finally, to investigate the test characteristics of 1,5-AG levels as a predictor of a 2h-PG level ≥200 mg/dL, we plotted a receiver operating characteristic (ROC) curve. The area under the ROC curve was 0.78, and the maximal sum of sensitivity and specificity (78% and 72%, respectively) was obtained at a 1,5-AG cutoff level of <14.2µg/mL. We conclude that 1,5-AG values may provide an ancillary predictor of 2h-PG of 75 g OGTTs in routine medical checkups.
Similar articles
-
Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.Acta Diabetol. 2017 May;54(5):463-470. doi: 10.1007/s00592-017-0968-z. Epub 2017 Feb 16. Acta Diabetol. 2017. PMID: 28210869
-
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.Diabetes Res Clin Pract. 2009 Apr;84(1):51-7. doi: 10.1016/j.diabres.2009.01.002. Epub 2009 Feb 1. Diabetes Res Clin Pract. 2009. PMID: 19187997
-
Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.Acta Diabetol. 2017 May;54(5):425-431. doi: 10.1007/s00592-016-0944-z. Epub 2016 Nov 28. Acta Diabetol. 2017. PMID: 27896445
-
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance.Clin Sci (Lond). 2001 Sep;101(3):227-33. Clin Sci (Lond). 2001. PMID: 11524039
-
Assessing postprandial glucose using 1,5-anhydroglucitol: An integrative literature review.J Am Acad Nurse Pract. 2009 Oct;21(10):542-8. doi: 10.1111/j.1745-7599.2009.00443.x. J Am Acad Nurse Pract. 2009. PMID: 19796288 Review.
Cited by
-
Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.Springerplus. 2015 Oct 9;4:587. doi: 10.1186/s40064-015-1389-5. eCollection 2015. Springerplus. 2015. PMID: 26543722 Free PMC article.
-
Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.Clin Chem. 2014 Nov;60(11):1409-18. doi: 10.1373/clinchem.2014.229427. Epub 2014 Sep 8. Clin Chem. 2014. PMID: 25200356 Free PMC article.
-
Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):690-695. doi: 10.4103/2230-8210.190559. Indian J Endocrinol Metab. 2016. PMID: 27730082 Free PMC article.
-
1,5-Anhydroglucitol in diabetes mellitus.Endocrine. 2013 Feb;43(1):33-40. doi: 10.1007/s12020-012-9760-6. Epub 2012 Jul 31. Endocrine. 2013. PMID: 22847316 Review.
-
Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population.Sci Rep. 2017 Sep 20;7(1):11968. doi: 10.1038/s41598-017-12210-z. Sci Rep. 2017. PMID: 28931928 Free PMC article.